1 / 24

Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis

Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis. Goals of Therapy for Patients With UC. Sequential Therapies for UC. Oral 5-ASA Formulations: Sites of Delivery. Conventional Corticosteroids in UC. Corticosteroids: Dependency — Short- and Long-term Efficacy.

chanda-roberts
Download Presentation

Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Treatment Advances in Achieving Remission in Mild to Moderate Ulcerative Colitis

  2. Goals of Therapy for Patients With UC

  3. Sequential Therapies for UC

  4. Oral 5-ASA Formulations: Sites of Delivery

  5. Conventional Corticosteroids in UC

  6. Corticosteroids: Dependency—Short- and Long-term Efficacy

  7. CORE I and II: Budesonide MMX Primary End Point: Combined Clinical and Endoscopic Remission

  8. Azathioprine vs 5-ASA for Corticosteroid-Dependent, Active UC

  9. Anti-TNF Therapies for Moderate to Severe Disease

  10. Treatment Algorithm to Maximize Remission and Minimize Corticosteroid Dependence in UC

  11. Patient Case

  12. Mesalamine Safety

  13. Patient Case (cont)

  14. Pooled Safety Data: Adverse Effects of Budesonide MMX in Patients With Active UC

  15. Anti-TNF Agents: Adverse Events

  16. Minimizing Toxicity for Anti-TNF Therapy

  17. Summary: Safety

  18. Effect on Bone Density

  19. Monitoring the Patient Receiving Budesonide MMX

  20. Summary: Safety of Agents Used to Induce Remission in Mild to Moderate UC

  21. Abbreviations

  22. References

  23. References (cont)

  24. References (cont)

More Related